Clinical Trials

Any further development efforts for either of our product candidates is dependent on our ability to raise additional capital.

Androxal®

We currently do not have any active clinical trials for Androxal.

If you have questions about Androxal, please call Repros at 800-895-6554 ext 3403 or email studyinfo@reprosrx.com.



Proellex®

If you are interested in participating, and want to know if you may qualify, please call 800-895-6554 ext 3401.


Current recruiting locations:


Alabama
Birmingham

Arizona
Phoenix
Tucson

Arkansas
Little Rock

Florida
Ft. Lauderdale
Jacksonville

Georgia
Atlanta
Kansas
Wichita

Louisiana
New Orleans

Michigan
Saginaw

North Carolina
Raleigh

South Carolina
Summerville
Tennessee
Jackson
Knoxville

Texas
Dallas
Houston

Utah
Riverton
Salt Lake City

Virgina
Richmond

Ongoing Studies

Proellex® - Treatment of Pre-Menopausal Women with Confirmed, Symptomatic Endometriosis (ZPE-202) (Currently recruiting)

Purpose: To determine the safety and efficacy of two doses of Proellex in premenopausal women with pelvic pain in endometriosis confirmed within the last seven years and using prescription analgesics for symptomatic pain.

Proellex® - Treatment of Pre-Menopausal Women with Confirmed, Symptomatic Uterine Fibroids (ZPU-203) (Currently recruiting)

Purpose: To determine the safety and efficacy of two oral doses of Proellex in premenopausal women with symptomatic uterine fibroids confirmed by MRI.

Proellex® - Treatment of Pre-Menopausal Women with Confirmed, Symptomatic Uterine Fibroids (ZPV-201) (Currently recruiting)

Purpose: To determine the safety and efficacy of two vaginal doses of Proellex in premenopausal women with symptomatic uterine fibroids confirmed by MRI.

2408 Timberloch Place, B-7
The Woodlands, Texas 77380
281-719-3400
281-719-3446 fax